Search Results - "Bowler RP"

Association of polycythemia with outcomes of acute decompensated heart failure: A matched and weighted cohort analysis.

Authors: Perets, Snir Minha, Sa'ar Maymon, Shiri L. et al.

Source: PLoS ONE. 4/20/2026, Vol. 21 Issue 4, p1-13. 13p.

Arsenic exposure is associated with elevated sweat chloride concentration and airflow obstruction among adults in Bangladesh: A cross-sectional study.

Authors: Lee, Mi-Sun S. North, Crystal M. Choudhuri, Irada et al.

Source: PLoS ONE. 5/7/2025, Vol. 20 Issue 5, p1-15. 15p.

COPD 2.0: Bronchodilators, biologics and beyond - A systematic review.

Authors: Shamim, Huda Singh, Anil Kumar Sharma, Rahul et al.

Source: Lung India. Jan/Feb2026, Vol. 43 Issue 1, p62-66. 5p.

Dynamic changes of lung sRAGE in mice with chronic obstructive pulmonary disease induced by cigarette smoke exposure.

Authors: He, Yue Liang, Hongyu Yang, Xiaohui et al.

Source: PLoS ONE. 11/26/2024, Vol. 19 Issue 11, p1-15. 15p.

Rehabilitation after bone marrow transplant compared with usual care to improve patient outcomes (REBOOT): protocol for a randomised controlled trial.

Authors: Denehy, Linda Abo, Shaza Swain, Christopher et al.

Source: BMC Cancer. 3/25/2025, Vol. 25 Issue 1, p1-18. 18p.

Supervised Multimodal Fission Learning.

Authors: Mao, Lingchao Wang, Qi Su, Yi et al.

Source: INFORMS Journal on Data Science. Jan2026, p1. 19p.

Lung Volume Reduction Therapies in Patients with Emphysema: A Systematic Review and Network Meta-Analysis.

Authors: Bo, Liyan He, Xu Chen, Yan et al.

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease. Dec2025, Vol. 22 Issue 1, p1-17. 17p.

Lung Function Decline in COPD – Relations to Changes in Symptom Burden, Inflammation, and Comorbidities.

Authors: Wang, Juan Ställberg, Björn Hårdstedt, Maria et al.

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease. Dec2025, Vol. 22 Issue 1, p1-11. 11p.

Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review.

Authors: Kelsen, Steven G. Maurer, Marcus Waters, Michael et al.

Source: Respiratory Research. 10/29/2025, Vol. 26 Issue 1, p1-9. 9p.

The effect of nicotine delivery system on blood protease levels: a randomized crossover study.

Authors: Wilson, Ava C. Leavens, Eleanor L. S. Covarrubias-Zambrano, Obdulia et al.

Source: Scientific Reports. 10/14/2025, Vol. 15 Issue 1, p1-10. 10p.

Behaviour change techniques embedded in physical training protocol on exercise motivation and level of physical activity in individuals with COPD: study protocol for a randomized controlled trial.

Authors: Basso, Fernanda Manenti Araújo, Tiago de Almeida Zopelari, Livia Maria Petilli et al.

Source: Trials. 10/8/2025, Vol. 26 Issue 1, p1-13. 13p.

Bidirectional genetic links between chronic obstructive pulmonary disease and frailty: Genome-wide association study insights.

Authors: Yan, Fuhui Wu, Tong Meng, Qiang et al.

Source: PLoS ONE. 5/29/2025, Vol. 20 Issue 5, p1-15. 15p.

Sphingolipid metabolism-related genes as diagnostic markers in pneumonia-induced sepsis: the AUG model.

Authors: Wu, Jing Li, Xiaomin Chen, Zhihao et al.

Source: Scientific Reports. 5/20/2025, Vol. 15 Issue 1, p1-14. 14p.

Multi-omics characterization of early chronic obstructive pulmonary disease.

Authors: Li, Bolun Liu, Jiangfeng Cao, Yinghao et al.

Source: Respiratory Research. 4/28/2025, Vol. 26 Issue 1, p1-12. 12p.

A generalized higher-order correlation analysis framework for multi-omics network inference.

Authors: Liu, Weixuan Pratte, Katherine A. Castaldi, Peter J. et al.

Source: PLoS Computational Biology. 4/14/2025, Vol. 21 Issue 4, p1-33. 33p.

The Relationship Between Iron Stores, Type 2 Diabetes, and Diabetic Complications.

Authors: Ateş, Muhammet Saler, Tayyibe

Source: Istanbul Medical Journal. May2026, Vol. 27 Issue 2, p136-142. 7p.

Trajectory of the arterial-alveolar oxygen gradient in COPD for a decade.

Authors: Nagata, Kazuma Sato, Susumu Uemasu, Kiyoshi et al.

Source: PLoS ONE. 1/29/2025, Vol. 20 Issue 1, p1-14. 14p.

Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc Responder Analysis.

Authors: Beeh, Kai-Michael Scheithe, Karl Schmutzler, Heike et al.

Source: Pulmonary Therapy. Sep2025, Vol. 11 Issue 3, p443-459. 17p.

Isolation of phytochemicals and exploration the mechanism of Dolichandrone spathacea in the treatment of chronic bronchitis by integrating network pharmacology, molecular docking, and experimental validation.

Authors: Nguyen, Dang-Khoa Liu, Ta-Wei Chu, Man-Hsiu et al.

Source: Botanical Studies. 8/11/2025, Vol. 66 Issue 1, p1-18. 18p.

Hederasaponin C ameliorates chronic obstructive pulmonary disease pathogenesis by targeting TLR4 to inhibit NF-κB/MAPK signaling pathways.

Authors: Ning, Yujie Huang, Liting Wang, Qin-Qin et al.

Source: Chinese Medicine. 7/2/2025, Vol. 20, p1-17. 17p.